XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net income $ 3,210 $ 1,954
Adjustments to reconcile net income to net cash used in operating activities    
Depreciation and amortization 2,060 1,035
Amortization of debt discount 904 130
Stock-based compensation 1,487 1,252
Shares issued for services 100 85
Gain on forgiveness of Paycheck Protection Program (1,552)
Gain on settlement of Seller Note (1,538)
Change in fair value of Convertible Loan (166)
Allowance for doubtful accounts 105 (274)
Increase in notes due to in-kind interest 467
Loss on debt waiver consent 1,212
Loss on warrant amendment 345
Loss/(Gain) on settlement of obligations 237 (359)
Gain on change in fair value of contingent consideration (369)
Gain on change in fair value of warrants (7,902)
Changes to operating assets and liabilities:    
Accounts receivable and unbilled receivables (2,835) (154)
Inventories (1,032) 399
Prepaid expenses and other current assets 682 (1,010)
Operating lease right-of-use assets, net (556) 219
Other assets 22
Accounts payable (227) (94)
Deferred revenue 1,019 6
Accrued expenses 533 (181)
Deposits (585) (402)
Operating liabilities, net (36)
Operating lease liabilities, non-current 576 (184)
Net cash used in operating activities (1,050) (367)
Investing activities    
Acquisition of business, net of cash acquired (17,186)
Purchases of property and equipment (123) (10)
Capitalization of labor for software development (2,959) (422)
Net cash used in investing activities (20,268) (432)
Financing activities    
Principal payments on finance leases (4)
Proceeds from sale of common stock in PIPE, net of offering expenses 1,814
Proceeds from sale & exercise of pre-funded warrants in PIPE, net of offering expenses 8,295
Proceeds from Acquisition Loan, net of offering expenses 9,868
Repayment of Seller Note (723) (100)
Proceeds from sale of shares via registered direct offering, net 1,849
Net cash provided by financing activities 19,254 1,745
Increase/(decrease) in Cash and Cash Equivalents (2,064) 946
Cash and Cash Equivalents, beginning of period 2,883 1,826
Cash and Cash Equivalents, end of period $ 819 $ 2,772